During the past decade, Istituto Europeo di Oncologia - Divisione di Oncologia Toracica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Europeo di Oncologia - Divisione di Oncologia Toracica" #1 collaborator was "Clinical Research Technology S.r.l." with 1 trials as a collaborator and "Clinical research technology Srl" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Europeo di Oncologia - Divisione di Oncologia Toracica" are "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Squamous-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Istituto Europeo di Oncologia - Divisione di Oncologia Toracica" in a lesser frequency.

Most popular intervention types in "Istituto Europeo di Oncologia - Divisione di Oncologia Toracica" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Crizotinib" (1 trials), "Lorlatinib" (1 trials), "Nivolumab plus Ipilimumab" (1 trials) and "Platinum-based chemotherapy plus Nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Europeo di Oncologia - Divisione di Oncologia Toracica" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Istituto Europeo di Oncologia - Divisione di Oncologia Toracica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Istituto Europeo di Oncologia - Divisione di Oncologia Toracica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Europeo di Oncologia - Divisione di Oncologia Toracica, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".